Cargando…
Efficacy of topical risedronate and risedronate - Eudragit E complex in a model of cutaneous leishmaniasis induced by Leishmania (Leishmania) amazonensis
An efficacious topical treatment for cutaneous leishmaniasis (CL) is highly desirable but still an ongoing challenge. Systemic risedronate (Ris) has been reported to have anti-leishmanial properties and Eudragit EPO (EuE) has shown in vitro activity against L. (L.) amazonensis. The aim of this work...
Autores principales: | Peralta, Ma. Florencia, Guzman, Ma. Laura, Bracamonte, Ma. Estefanía, Marco, J. Diego, Olivera, Ma. Eugenia, Carrer, Dolores C., Barroso, Paola A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173260/ https://www.ncbi.nlm.nih.gov/pubmed/34124403 http://dx.doi.org/10.1016/j.heliyon.2021.e07136 |
Ejemplares similares
-
Successful treatment of diffuse cutaneous leishmaniasis caused by Leishmania amazonensis()()
por: Sampaio, Raimunda Nonata Ribeiro, et al.
Publicado: (2021) -
Draft Genome Sequences of Leishmania (Leishmania) amazonensis, Leishmania (Leishmania) mexicana, and Leishmania (Leishmania) aethiopica, Potential Etiological Agents of Diffuse Cutaneous Leishmaniasis
por: Batra, Dhwani, et al.
Publicado: (2019) -
Visceral leishmaniasis caused by Leishmania (Leishmania) amazonensis associated with Hodgkin’s lymphoma
por: Porto, Victor Bertolo Gomes, et al.
Publicado: (2022) -
Exposure of Phosphatidylserine on Leishmania amazonensis Isolates Is Associated with Diffuse Cutaneous Leishmaniasis and Parasite Infectivity
por: França-Costa, Jaqueline, et al.
Publicado: (2012) -
Photodynamic Vaccination of BALB/c Mice for Prophylaxis of Cutaneous Leishmaniasis Caused by Leishmania amazonensis
por: Viana, Sayonara M., et al.
Publicado: (2018)